These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

229 related articles for article (PubMed ID: 29337194)

  • 21. Rho-kinase inhibitor, fasudil, prevents neuronal apoptosis via the Akt activation and PTEN inactivation in the ischemic penumbra of rat brain.
    Wu J; Li J; Hu H; Liu P; Fang Y; Wu D
    Cell Mol Neurobiol; 2012 Oct; 32(7):1187-97. PubMed ID: 22552888
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Fasudil attenuates mitochondrial injury and apoptosis in rat model of myocardial ischemia/reperfusion injury].
    Ye H; Zhang G; Cao R; Kang P; Li Z; Gao Q
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2017 Jul; 33(7):909-914. PubMed ID: 28712398
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Mechanisms of favorable effects of Rho kinase inhibition on myocardial remodeling and systolic function after experimental myocardial infarction in the rat.
    Mera C; Godoy I; Ramírez R; Moya J; Ocaranza MP; Jalil JE
    Ther Adv Cardiovasc Dis; 2016 Feb; 10(1):4-20. PubMed ID: 26490279
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A novel pathway of NADPH oxidase/vascular peroxidase 1 in mediating oxidative injury following ischemia-reperfusion.
    Zhang YS; He L; Liu B; Li NS; Luo XJ; Hu CP; Ma QL; Zhang GG; Li YJ; Peng J
    Basic Res Cardiol; 2012 May; 107(3):266. PubMed ID: 22476986
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Rho-Kinase inhibitor fasudil suppresses high glucose-induced H9c2 cell apoptosis through activation of autophagy.
    Gao H; Hou F; Dong R; Wang Z; Zhao C; Tang W; Wu Y
    Cardiovasc Ther; 2016 Oct; 34(5):352-9. PubMed ID: 27333569
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Chronic Rho-kinase inhibition improves left ventricular contractile dysfunction in early type-1 diabetes by increasing myosin cross-bridge extension.
    Waddingham MT; Edgley AJ; Astolfo A; Inagaki T; Fujii Y; Du CK; Zhan DY; Tsuchimochi H; Yagi N; Kelly DJ; Shirai M; Pearson JT
    Cardiovasc Diabetol; 2015 Jul; 14():92. PubMed ID: 26194354
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Fasudil evokes vasodilatation of rat mesenteric vascular bed via Ca(2+) channels and Rho/ROCK pathway.
    Chen YC; Yuan TY; Zhang HF; Wang DS; Niu ZR; Li L; Fang LH; Du GH
    Eur J Pharmacol; 2016 Oct; 788():226-233. PubMed ID: 27346833
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Protective Effects of a Rho Kinase Inhibitor on Paraquat-Induced Acute Lung Injuries in Rats.
    Zhang L; Li Q; Liu Z; Liu W; Zhao M
    Inflammation; 2018 Dec; 41(6):2171-2183. PubMed ID: 30088170
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Rho-kinase/myosin light chain kinase pathway plays a key role in the impairment of bile canaliculi dynamics induced by cholestatic drugs.
    Sharanek A; Burban A; Burbank M; Le Guevel R; Li R; Guillouzo A; Guguen-Guillouzo C
    Sci Rep; 2016 May; 6():24709. PubMed ID: 27169750
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Protective effects of fasudil hydrochloride post-conditioning on acute myocardial ischemia/reperfusion injury in rats.
    Jiang ZH; Zhang TT; Zhang JF
    Cardiol J; 2013; 20(2):197-202. PubMed ID: 23558879
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Inhibition of MiRNA-125b Decreases Cerebral Ischemia/Reperfusion Injury by Targeting CK2α/NADPH Oxidase Signaling.
    Liang Y; Xu J; Wang Y; Tang JY; Yang SL; Xiang HG; Wu SX; Li XJ
    Cell Physiol Biochem; 2018; 45(5):1818-1826. PubMed ID: 29510389
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Neuroprotective potential of fasudil mesylate in brain ischemia-reperfusion injury of rats.
    Li Q; Huang XJ; He W; Ding J; Jia JT; Fu G; Wang HX; Guo LJ
    Cell Mol Neurobiol; 2009 Mar; 29(2):169-80. PubMed ID: 18785000
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Neuroprotective Effects of Fasudil, a Rho-Kinase Inhibitor, After Spinal Cord Ischemia and Reperfusion in Rats.
    Ohbuchi M; Kimura T; Nishikawa T; Horiguchi T; Fukuda M; Masaki Y
    Anesth Analg; 2018 Mar; 126(3):815-823. PubMed ID: 29099428
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Rho kinase inhibition by fasudil attenuates cyclosporine-induced kidney injury.
    Park JW; Park CH; Kim IJ; Bae EH; Ma SK; Lee JU; Kim SW
    J Pharmacol Exp Ther; 2011 Jul; 338(1):271-9. PubMed ID: 21474569
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Long-term administration of fasudil improves cardiomyopathy in streptozotocin-induced diabetic rats.
    Guan SJ; Ma ZH; Wu YL; Zhang JP; Liang F; Weiss JW; Guo QY; Wang JY; Ji ES; Chu L
    Food Chem Toxicol; 2012 Jun; 50(6):1874-82. PubMed ID: 22429817
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Rho kinase inhibition by fasudil ameliorates diabetes-induced microvascular damage.
    Arita R; Hata Y; Nakao S; Kita T; Miura M; Kawahara S; Zandi S; Almulki L; Tayyari F; Shimokawa H; Hafezi-Moghadam A; Ishibashi T
    Diabetes; 2009 Jan; 58(1):215-26. PubMed ID: 18840783
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Fasudil improves the endothelial dysfunction in the aorta of spontaneously hypertensive rats.
    Tsounapi P; Saito M; Kitatani K; Dimitriadis F; Ohmasa F; Shimizu S; Kinoshita Y; Takenaka A; Satoh K
    Eur J Pharmacol; 2012 Sep; 691(1-3):182-9. PubMed ID: 22819709
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Chronic treatment with an oral rho-kinase inhibitor restores erectile function by suppressing corporal apoptosis in diabetic rats.
    Li WJ; Park K; Paick JS; Kim SW
    J Sex Med; 2011 Feb; 8(2):400-10. PubMed ID: 20233282
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Diabetes aggravates myocardial ischaemia reperfusion injury via activating Nox2-related programmed cell death in an AMPK-dependent manner.
    Wang C; Zhu L; Yuan W; Sun L; Xia Z; Zhang Z; Yao W
    J Cell Mol Med; 2020 Jun; 24(12):6670-6679. PubMed ID: 32351005
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effect of the myosin light chain kinase inhibitor ML-7 on the proteome of hearts subjected to ischemia-reperfusion injury.
    Lin HB; Cadete VJ; Sawicka J; Wozniak M; Sawicki G
    J Proteomics; 2012 Sep; 75(17):5386-95. PubMed ID: 22749930
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.